Microbial process for preparation of glucuronides of raloxifene

Journal of Industrial Microbiology and Biotechnology

Volumn 23, Issue 3, 1999, Pages 194-197

  Briggs, B S ^a   Baker, P J ^a   Belvo, M D ^a   Black, T D ^a   Getman, B G ^a   Kemp, C A J ^a   Muth, W L ^a   Perun, T J ^a   Strobel Jr , R J ^a   Paschal, J W ^a   Zmijewski, M J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Glucuronidation; Raloxifene; Streptomyces sp NRRL 21489

Indexed keywords

RALOXIFENE;

ARTICLE; BIOTRANSFORMATION; CHEMICAL STRUCTURE; DRUG DECOMPOSITION; DRUG PURIFICATION; GLUCURONIDATION; NONHUMAN; OSTEOPOROSIS; SPECTROSCOPY; STANDARD;

EID: 0032757585     PISSN: 13675435     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jim.2900716     Document Type: Article

References (11)

1. 1 Beresford SA, NS Weiss, LF Voigt and B McKnight. 1997. Risk of endometrial cancer in relation to use of estrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet 349: 458-461.
2. 2 Briggs BS and MJ Zmijewski. 1996. Process for preparation of benzo[B] thiophene glucuronides. Eli Lilly and Co. US patent 5 563 054.
3. 3 Cacsinelli G, M Ballabio, A Grein, S Merli, G Rivola, F Arcamone, B Barbieri and T Bordoni. 1987. A new class of biosynthetic anthracyclinone: anthracyclinone glucuronides. J Antibiot 40: 1071-1074.
4. 4 Chen TS, L So, R White and RL Monaghan. 1993. Microbial hydroxylation and glucuronidation of the angiotensin II (AII) receptor antagonist MK 954. J Antibiot 46: 131-134.
5. 5 Chowdhury SK and BT Chait. 1991. Method for the electrospray ionization of highly conductive aqueous solutions. Anal Chem 63: 1660-1666.
6. 6 Delmar PD. 1997. Estrogen and estrogen-like substances in women's health: the year 2000. Fr Osteoporosis Int 7 (Suppl 1): 3-7.
7. 7 Dodge JA, CW Lugar, S Cho, JJ Osborn, DL Phillips. AL Glasebrook and CA Frolik. 1997. Synthesis and estrogen receptor binding affinities of the major human metabolites of raloxifene (LY139481). Bioorg Med Chem Lett 7: 993-996.
8. 8 Marcus R. 1997. Use of estrogen for prevention and treatment of osteoporosis. Endocrine 6: 207-211.
9. 9 Nakagawa M, H Kawai, Y Hayakawa, H Seto and N Otake. 1985. 4-O-(β-D-Glucupyranosyl)-∈-rhodomycinone, a new microbial transformation product of rhodomycinone. Antibiotics 38: 1622-1624.
10. 10 Smith RV and JP Rosazza. 1982. Microbial Transformations of Bioactive Compounds. Vol II, Ch 1, CRC Press, Florida.
11. 11 Zumoff B. 1993. Biological and endocrinological insights into the possible breast cancer risk from menopausal estrogen replacement therapy. Steroids 58: 196-204.